XENO Stock Chart & Stats
$0.10
$0.00(0.00%)
At close: 4:00 PM EDT
$0.10
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.10 - $0.10
Previous CloseN/A
Volume10.00K
Average Volume (3M)0.00
Market Cap
$4.04K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.00
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding40,364,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
XENO FAQ
What was Xeno Transplants Corporation’s price range in the past 12 months?
Xeno Transplants Corporation lowest stock price was $0.10 and its highest was $0.10 in the past 12 months.
What is Xeno Transplants Corporation’s market cap?
Xeno Transplants Corporation’s market cap is $4.04K.
When is Xeno Transplants Corporation’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Xeno Transplants Corporation’s earnings last quarter?
Currently, no data Available
Is Xeno Transplants Corporation overvalued?
According to Wall Street analysts Xeno Transplants Corporation’s price is currently Overvalued.
Does Xeno Transplants Corporation pay dividends?
Xeno Transplants Corporation does not currently pay dividends.
What is Xeno Transplants Corporation’s EPS estimate?
Xeno Transplants Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Xeno Transplants Corporation have?
Xeno Transplants Corporation has 40,364,000 shares outstanding.
What happened to Xeno Transplants Corporation’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Xeno Transplants Corporation?
Currently, no hedge funds are holding shares in XENO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Xeno Transplants Corporation
Xeno Transplants Corporation functions as a biotechnology firm dedicated to research and development. Leveraging a specific licensing agreement with Massachusetts General Hospital, the company aims to innovate, produce, commercialize, and implement products and methodologies for public application in the field of xenotransplantation. The primary objective of this xenotransplantation research is to alleviate the critical scarcity of human cells, tissues, and organs required for medical transplants. This is achieved by pioneering techniques that enable the transfer of biological components—such as cells, tissues, and organs—from non-human species, including pigs, into human recipients. Established in 2004, Xeno Transplants Corporation maintains its headquarters in Brookline, Massachusetts.